Research ArticleOriginal Article
Open Access
Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
Mosaad O. Almegren, Saleh H. Alharbi, Turki A. Alshuaibi, Mohammed M. Almansour, Khalid A. Alharbi, Bader Al Rawahi, Abdulmajeed K. Al Balushi, Abdulrahman A. Alraizah and Farjah H. Alqahtani
Neurosciences Journal January 2024, 29 (1) 32-36; DOI: https://doi.org/10.17712/nsj.2024.1.20230050
Mosaad O. Almegren
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MDSaleh H. Alharbi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MDTurki A. Alshuaibi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MDMohammed M. Almansour
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MBBSKhalid A. Alharbi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MBBSBader Al Rawahi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MDAbdulmajeed K. Al Balushi
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MBBSAbdulrahman A. Alraizah
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MDFarjah H. Alqahtani
From the Department of Medicine (Almegren, Alharbi S), College of Medicine, Imam Mohammad Ibn Saud Islamic University, from the Department of Oncology (Alraizah), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Department of Medicine (Alshuaibi, Alharbi K, Almansour), King Fahad Hospital, Jeddah, and from the Division of Hematology (Alqahtani), Department of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia, and from the Department of Hematology (Al Rawahi), College of Medicine and Health Sciences (Al Balushi), Sultan Qaboos University Hospital, Muscat, Oman.
MDIn this issue
Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
Mosaad O. Almegren, Saleh H. Alharbi, Turki A. Alshuaibi, Mohammed M. Almansour, Khalid A. Alharbi, Bader Al Rawahi, Abdulmajeed K. Al Balushi, Abdulrahman A. Alraizah, Farjah H. Alqahtani
Neurosciences Journal Jan 2024, 29 (1) 32-36; DOI: 10.17712/nsj.2024.1.20230050
Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study
Mosaad O. Almegren, Saleh H. Alharbi, Turki A. Alshuaibi, Mohammed M. Almansour, Khalid A. Alharbi, Bader Al Rawahi, Abdulmajeed K. Al Balushi, Abdulrahman A. Alraizah, Farjah H. Alqahtani
Neurosciences Journal Jan 2024, 29 (1) 32-36; DOI: 10.17712/nsj.2024.1.20230050
Jump to section
Related Articles
- No related articles found.